A randomised open label study to assess the effects of Calcium and Vitamin D supplementation on residual ridge resorption in ageing edentulous patients.

Indian Council of Medical Research0 sites150 target enrollmentTBD

ConditionsHealth Condition 1: null- Completely edentulous patientsHealth Condition 2: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified

Overview

Phase: 未知
Intervention: Not specified
Conditions: Health Condition 1: null- Completely edentulous patientsHealth Condition 2: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified
Sponsor: Indian Council of Medical Research
Enrollment: 150
Status: Completed
Last Updated: 4 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

4 years ago

Study Type

Interventional

Investigators

Sponsor

Indian Council of Medical Research

Eligibility Criteria

Inclusion Criteria

•1\.Non\-smoking and non\-alcohol drinking completely edentulous patients aged 60 years or above, who are not under medication for any oral, metabolic, skeletal, renal or endocrine disease or previous Calcium and/or Vitamin D supplementation.
•2\. All patients must have been edentulous for more than 1 year as the size of the residual ridge is reduced most rapidly in the first six months, which gradually decreases to a steady rate.
•3\.Class I and 2 edentulous subject with moderate alveolar ridge atrophy. (2\)
•4\.Subjects with a philosophical mind set (MM House classification) as such patients recognize their responsibility of being an active partner in the treatment. They would probably be more compliant with recall appointments and denture wearing instructions.

Exclusion Criteria

•1\.Patients having smoking and/or alcohol drinking habit.
•2\.Patients on previous Calcium or Vitamin D supplements.
•3\.Previous denture wearers.
•4\.Mild or severely resorbed alveolar ridges, or ridges having a class II / III ridge relation.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting

Not Applicable

A study for evaluation of utility of indomethacin in tuberculous meningitis patientsHealth Condition 1: null- Tuberculous Meningitis

CTRI/2018/02/011722Dr Ravi Uniyal

Active, not recruiting

Phase 1

Maraviroc switch study

EUCTR2011-002107-15-GBniversity of New South Wales380

Recruiting

Phase 4

A randomised, open-label study to evaluate the efficacy and safety of maraviroc (MVC) as a switch for either nucleoside or nucleotide analogue reverse transcriptase inhibitors (N(t)RTI) or boosted protease inhibitors (PI/r) in HIV-1 infected individuals with stable, well-controlled plasma HIV-RNA while taking their first N(t)RTI + PI/r regimen of combination antiretroviral therapy (cART): MARCH studyHIVInflammatory and Immune System - Other inflammatory or immune system disordersInfection - Acquired immune deficiency syndrome (AIDS / HIV)

ACTRN12611000816954niversity of New South Wales, Kirby Institute560

Active, not recruiting

Not Applicable

Open-label, prospective study to assess the effects of formoterol and beclometasone dipropionate combination therapy on central and peripheral airway dimensions in asthmatic patients

EUCTR2008-002391-97-BEniversity Hospital Antwerp; Department Respiratory Medicine

Active, not recruiting

Not Applicable

EXCITE-HT study

JPRN-jRCTs031220372Kario Kazuomi540